Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Teriparatide for stress fracture healing and return to duty in recruits
2018-002130-20Phase 3Unknown
- Sponsor
- Norfolk and Norwich University Hospitals NHS Foundation Trust
- Start
- Jun 2019
- Modality
- Recombinant Proteins and Enzymes, Peptides
- Countries
- 1
01
Overview
Phase 3, randomised trial of ZT-034 in stress fracture (2 arms), sponsored by Norfolk and Norwich University Hospitals NHS Foundation Trust. Primary endpoint: Radiological healing at 8 weeks. Status: unknown.
02
Drugs
ZT-034
03
Conditions
stress fracture
Beyond the preview
Go deeper on 2018-002130-20.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2018-002130-20.